Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 272

    Lupin appoints Nicholas Hart as head of specialty business in US

    Lupin appoints Nicholas Hart as head of specialty business in US

    Ruby Khatun Khatun3 Jun 2018 10:15 AM IST
    New Delhi: Drug maker Lupin said it has appointed Nicholas Hart as President of its Specialty business in the US.Hart will lead the specialty...
    Apollo Hospitals Q4 net dips 43 percent to Rs 36 crore

    Apollo Hospitals Q4 net dips 43 percent to Rs 36 crore

    Ruby Khatun Khatun3 Jun 2018 10:00 AM IST
    New Delhi: Apollo Hospitals reported 42.6 percent decline in its consolidated profit after tax at Rs 35.7 crore for the fourth quarter ended March...
    Allergan to sell womens health, infectious disease units

    Allergan to sell women's health, infectious disease units

    Ruby Khatun Khatun3 Jun 2018 9:45 AM IST
    NEW YORK: Drugmaker Allergan Plc said it plans to sell two of its smaller businesses, the women’s health, and infectious disease units, as Chief...
    AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

    AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

    Ruby Khatun Khatun3 Jun 2018 9:30 AM IST
    AstraZeneca’s first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate...
    Lupin launches oral antibiotic Solosec in US

    Lupin launches oral antibiotic Solosec in US

    Ruby Khatun Khatun2 Jun 2018 10:30 AM IST
    New Delhi: Drug major Lupin said it has launched Solosec, an oral antibiotic used in treating bacterial vaginosis (BV) in women, in the US market.The...
    Granules Indias US arm launches generic Methergine tablets in US market

    Granules India's US arm launches generic Methergine tablets in US market

    Ruby Khatun Khatun2 Jun 2018 10:15 AM IST
    New Delhi: Granules India Ltd said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership...
    AstraZeneca expands its GMD Centre in India

    AstraZeneca expands its GMD Centre in India

    Ruby Khatun Khatun2 Jun 2018 10:00 AM IST
    Global science-led biopharmaceutical company AstraZeneca officially opened its new Global Medicines Development (GMD) Centre in Bengaluru, India.This...
    Pfizer receives FDA breakthrough therapy designation for XALKORI

    Pfizer receives FDA breakthrough therapy designation for XALKORI

    Ruby Khatun Khatun2 Jun 2018 9:45 AM IST
    NEW YORK: Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for XALKORI® (crizotinib)...
    Roche, chasing Merck, notches another lung cancer win

    Roche, chasing Merck, notches another lung cancer win

    Ruby Khatun Khatun2 Jun 2018 9:30 AM IST
    ZURICH: Roche’s bid to keep Merck’s cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker said its...
    Fortis sells 18.2 million units of RHT Health Trust

    Fortis sells 18.2 million units of RHT Health Trust

    Ruby Khatun Khatun1 Jun 2018 11:00 AM IST
    New Delhi: Fortis Healthcare said one of its subsidiaries has sold off 18.2 million units of RHT Health Trust for 13.65 million SGD (around Rs 69...
    Lupin recalls 43,922 cartons of contraceptive pills from US

    Lupin recalls 43,922 cartons of contraceptive pills from US

    Ruby Khatun Khatun1 Jun 2018 10:45 AM IST
    Hyderabad: Lupin Pharmaceuticals has initiated a voluntary recall of 43,922 cartons of My Way (levonorgestrel) tablets from the US market as they were...
    Torrent Pharma Q4 net up 11 percent at Rs 228 crore

    Torrent Pharma Q4 net up 11 percent at Rs 228 crore

    Ruby Khatun Khatun1 Jun 2018 10:30 AM IST
    New Delhi: Torrent Pharmaceuticals posted 11 percent increase in consolidated net profit at Rs 228 crore for the fourth quarter ended March 2018,...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok